Export

ATC codes: P02CB02
EMLc
Indication
Lymphatic filariasis ICD11 code: 1F66.3
INN
Diethylcarbamazine
Medicine type
Chemical agent
List type
Core
Formulations
Oral > Solid: 50 mg tablet (dihydrogen citrate) ; 100 mg tablet (dihydrogen citrate)
EML status history
First added in 1979 (TRS 641)
Changed in 1997 (TRS 882)
Changed in 2003 (TRS 920)
Changed in 2007 (TRS 950)
Changed in 2011 (TRS 965)
Sex
All
Age
Also recommended for children
Therapeutic equivalence
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Summary of evidence and Expert Committee recommendations
For antifilarials, based on the evidence provided, the Committee decided to retain ivermectin and diethylcarbamazine, and add albendazole for combination therapy for both children and adults. There was no reason for diethylcarbamazine to be on the Complementary List especially since it is recommended by WHO guidelines as the medicine of choice for mass drug administration in countries endemic for lymphatic filariasis but without either onchocerciasis or loiasis.